Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)
| 1.08 Delayed Data As of Feb 02 |  0.00 / 0.00%Today’s Change | 0.91 Today|||52-Week Range 9.37 | -6.09% Year-to-Date |
Latest SONN News | Press Releases
No recent news for Sonnet Biotherapeutics Holdings Inc.
Today’s Trading
| Previous close | 1.08 |
| Today’s open | 1.11 |
| Day’s range | 1.08 - 1.11 |
| Volume | 1,635 |
| Average volume (3 months) | 3,240,794 |
| Market cap | $8.8M |
Data as of 4:00pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | +52.03% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -27.64% |
| P/E ratio | NM |
| Price/Sales | 18.27 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 7, 2023 |
| EPS forecast (this quarter) | -$1.13 |
| Annual revenue (last year) | $349.9K |
| Annual profit (last year) | -$29.7M |
| Net profit margin | -8,493.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
